Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of contrast-induced kidney injury in patients undergoing contrast arteriography
RBR-3h2gv8rTerminated
- Sponsor
- Hospital Alberto Rassi
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of acetylcysteine, atorvastatin and sodium chloride in acute kidney failure (AKF) (6 arms), sponsored by Hospital Alberto Rassi. Started Feb 2022; status: terminated.
02
Drugs
acetylcysteineatorvastatinsodium chloride
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on RBR-3h2gv8r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3h2gv8r.